Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Reschke CR, Silva LFA, Vangoor VR, Rosso M, David B, Cavanagh BL, Connolly NMC, Brennan GP, Sanz-Rodriguez A, Mooney C, Batool A, Greene C, Brennan M, Conroy RM, Rüber T, Prehn JHM, Campbell M, Pasterkamp RJ, Henshall DC.

Journal title: Molecular Therapy

Journal publisher: Nature Publishing Group

Published year: 2021

DOI identifier: 10.1016/j.ymthe.2021.02.021

ISSN: 1525-0016